☰

Rameen Beroukhim, M.D. Ph.D.

Affiliations: 
Cancer Biology, Medical Oncology Dana-Farber Cancer Institute, Boston, MA, United States 
 Cancer Program Broad Institute (MIT/Harvard) 
 Medicine Harvard Medical School 
Area:
neuroscience, structural biology, computational biology, oncology, genomics
Website:
https://beroukhimlab.org
Google:
"Rameen Beroukhim"
Mean distance: 17.99 (cluster 51)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Nigel Unwin grad student 1991-1996 MRC-LMB
William Raj Sellers post-doc 2003-2006 Dana-Farber Cancer Institute
Matthew Meyerson post-doc 2005-2009 Dana-Farber Cancer Institute

Children

Sign in to add trainee
John Prensner research assistant Dana-Farber Cancer Institute
Guillaume Bergthold grad student Dana-Farber Cancer Institute
William Gibson grad student Dana-Farber Cancer Institute and Harvard Medical School
Prasidda Khadka grad student Dana-Farber Cancer Institute and Harvard Medical School
Jeff Meng grad student Dana-Farber Cancer Institute
Caitlin Nichols grad student Dana-Farber Cancer Institute and Harvard Medical School
Jeremiah Wala grad student Dana-Farber Cancer Institute and Harvard Medical School
Travis Zack grad student Dana-Farber Cancer Institute and Harvard Medical School
Pratiti Bandopadhayay post-doc Dana-Farber Cancer Institute
Uri Ben-David post-doc Broad Institute (MIT/Harvard)
Wenya L. Bi post-doc Brigham and Women's Hospital / Harvard Medical School
Frank Dubois post-doc Dana-Farber Cancer Institute
Peleg M. Horowitz post-doc Dana-Farber Cancer Institute and Harvard Medical School
Brenton Paolella post-doc Dana-Farber Cancer Institute
Zachary Reitman post-doc Dana-Farber Cancer Institute
Cecile Rouleau post-doc Dana-Farber Cancer Institute
Simona Dalin post-doc 2019-
Ofer Shapira research scientist Dana-Farber Cancer Institute

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lim-Fat MJ, Iorgulescu JB, Rahman R, et al. (2024) Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Giacomini G, Piquet S, Chevallier O, et al. (2024) Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors. Nucleic Acids Research
Chukwu W, Lee S, Crane A, et al. (2023) Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals. Biorxiv : the Preprint Server For Biology
Dalin S, Webster S, Sugawara N, et al. (2023) Double-strand break repair-associated intragenic deletions and tandem duplications suggest the architecture of the repair replication fork. Biorxiv : the Preprint Server For Biology
Rahman R, Trippa L, Lee EQ, et al. (2023) Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300493
Shih J, Sarmashghi S, Zhakula-Kostadinova N, et al. (2023) Cancer aneuploidies are shaped primarily by effects on tumour fitness. Nature
Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, et al. (2023) Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nature Genetics
Blandin AF, Giglio R, Graham MS, et al. (2023) ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Li Y, Roberts ND, Wala JA, et al. (2023) Author Correction: Patterns of somatic structural variation in human cancer genomes. Nature
Rheinbay E, Nielsen MM, Abascal F, et al. (2023) Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature
See more...